ASCEND - A Randomised, double-blinded phase II study of gemcitabine and nab-paclitaxel with CEND-1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma (NCT05042128)
ASCEND
This trial is No longer recruiting
Registration number NCT05042128
Program & service
This trial is being run with the Cancer service, and as part of the Medical Oncology program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Sanjeev Gill
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR